Radiopharmaceuticals

Application 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) is a macrocyclic complexing agent. It has been used for radiolabeling of carbon nanotube bioconjugates by chelating 64 Cu radioisotope.

Application 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) is a macrocyclic complexing agent. It has been used for radiolabeling of carbon nanotube bioconjugates by chelating 64 Cu radioisotope.

Applications：3,6-Dibromo-9H-fluoren-9-one is a reagent in the preparation of diphenylamine-fluorenone derivatives as potential fluorescent probes for neuroblastoma cell staining.

Application Useful spin label for studying biological systems. Used to study molecular diffusion into horse spleen ferritin and has been shown to be an effective nonthiol radioprotector.

The human hepatocellular carcinoma (HCC) cells were treated with its inhibitor 4-(2-aminoethyl)benzenesulfonamide . Application 4-(2-Aminoethyl)benzenesulfonamide was used to develop a model system to study the implementation of a microfluid chip

Product IntroductionThe human hepatocellular carcinoma (HCC) cells were treated with its inhibitor 4-(2-aminoethyl)benzenesulfonamide.Application4-(2-Aminoethyl)benzenesulfonamide was used to develop a model system to study the implementation of a

Product IntroductionThe human hepatocellular carcinoma (HCC) cells were treated with its inhibitor 4-(2-aminoethyl)benzenesulfonamide.Application4-(2-Aminoethyl)benzenesulfonamide was used to develop a model system to study the implementation of a

Product IntroductionThe human hepatocellular carcinoma (HCC) cells were treated with its inhibitor 4-(2-aminoethyl)benzenesulfonamide.Application4-(2-Aminoethyl)benzenesulfonamide was used to develop a model system to study the implementation of a

Product IntroductionThe human hepatocellular carcinoma (HCC) cells were treated with its inhibitor 4-(2-aminoethyl)benzenesulfonamide.Application4-(2-Aminoethyl)benzenesulfonamide was used to develop a model system to study the implementation of a

5′-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine is a Capecitabine analog that shows anti-tumor activity.

6(5H)-Phenanthridinone is a small molecule poly(ADP-ribose) polymerase (PARP) inhibitor with immunosupperessive effects. 6(5H)-Phenanthridinone has been shown to inhibit concanavilin A-induced lymphocyte proliferation, producing the observed

6(5H)-Phenanthridinone is a small molecule poly(ADP-ribose) polymerase (PARP) inhibitor with immunosupperessive effects. 6(5H)-Phenanthridinone has been shown to inhibit concanavilin A-induced lymphocyte proliferation, producing the observed